| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | M Dobbelstein | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 291-334 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Replicating adenoviruses in cancer therapy | |
| P478 | volume | 273 |
| Q35641856 | A novel and simple method for rapid generation of recombinant porcine adenoviral vectors for transgene expression |
| Q35000513 | Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA. |
| Q34301861 | Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts |
| Q40018751 | Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication. |
| Q35850341 | Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival |
| Q37945220 | An update on canine adenovirus type 2 and its vectors |
| Q55365673 | Autophagy Benefits the Replication of Egg Drop Syndrome Virus in Duck Embryo Fibroblasts. |
| Q55499725 | Development of a Serum-free Suspension Process for the Production of a Conditionally Replicating Adenovirus using A549 Cells. |
| Q40541104 | E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection |
| Q40471271 | Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteins. |
| Q91938470 | Gene Therapy Tools for Brain Diseases |
| Q34353556 | Genetic identification of adenovirus type 5 genes that influence viral spread |
| Q35914457 | Investigation of adenovirus occurrence in pediatric tumor entities. |
| Q38023422 | Latest insights on adenovirus structure and assembly. |
| Q42010270 | Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid. |
| Q34109937 | Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas |
| Q36099082 | Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients. |
| Q38061306 | Oncolytic viruses & their specific targeting to tumour cells |
| Q38020107 | Oncolytic viruses in the treatment of cancer: a review of current strategies |
| Q34545667 | Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species |
| Q36923812 | Selective killing of Smad4-negative tumor cells via a designed repressor strategy |
| Q36276605 | Selective modification of adenovirus replication can be achieved through rational mutagenesis of the adenovirus type 5 DNA polymerase |
| Q37595513 | The current state of head and neck cancer gene therapy |
| Q36850878 | Viruses as anticancer drugs |
Search more.